Malta vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB
Malta
100.0%
in 2022
Western Pacific (WHO region)
86.0%
in 2024
Malta rank
1st
Western Pacific (WHO region) rank
3rd
Previously treated cases tested for RR-/MDR-TB over time
- Malta
- Western Pacific (WHO region)
How they compare
Malta currently reports 100.0% against 86.0% in Western Pacific (WHO region), a difference of 14.0%.
That makes Malta's figure about 1.2 times Western Pacific (WHO region)'s.
The two have swapped places 5 times across 8 shared years of data; in 2007 it was Western Pacific (WHO region) ahead.
Malta ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malta | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.3% | 1.3% | 13.1% | Malta |
| 2010s | 66.8% | 20.9% | 45.8% | Malta |
| 2020s | 100.0% | 83.0% | 17.0% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Malta or Western Pacific (WHO region)?
- Malta, at 100.0% against 86.0% in Western Pacific (WHO region) as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Malta and Western Pacific (WHO region)?
- 14.0%, with Malta ahead.
- How many years of comparable data are there for Malta and Western Pacific (WHO region)?
- 8 years are reported by both, from 2007 to 2022.
- How do Malta and Western Pacific (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Malta ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.